Several million people are addicted to methamphetamines and also use tobacco, cannabis, alcohol, benzos, and opioids.
Two new clinical trials highlight potential breakthroughs in addiction medicine: semaglutide significantly reduced alcohol intake in patients with obesity and alcohol use disorder, while mirtazapine ...
A phase III placebo-controlled trial published in the Journal of the American Medical Association demonstrated that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results